<DOC>
	<DOC>NCT01370161</DOC>
	<brief_summary>The purpose of this study is to determine whether early use of transjugular intrahepatic portosystemic shunt (TIPS) with Polytetrafluoroethylene (PTFE) covered stents is able to prolong the survival in cirrhotic patients with high risk acute variceal bleeding.</brief_summary>
	<brief_title>Early TIPS With Polytetrafluoroethylene (PTFE) Covered Stents for High Risk Acute Variceal Bleeding in Cirrhotic Patients</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>History of cirrhosis (clinical or by liver biopsy) Admission due to acute bleeding from oesophageal or gastric (GOV1 or GOV2) varices ChildPugh Class C (ChildPugh score less than or equal to 13) or ChildPugh class B Signed written informed consent Patients not fulfilling inclusion criteria Pregnancy or breastfeeding Confirmed hepatocellular carcinoma with any of the following characteristics: one nodule of more than 5 cm; more than 3 greater than 3 cm Creatinine greater than 3 mg/dl Terminal hepatic failure (ChildPugh score greater than 13) Previous treatment with TIPS or combined pharmacological and endoscopic treatment to prevent rebleeding Fundal or ectopic gastric variceal bleeding (IGV1 or IGV2) Portal vein thrombosis or cavernoma Congestive heart failure New York Heart Association (NYHA) greater than III or medical history of pulmonary hypertension Spontaneous recurrent hepatic encephalopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>transjugular intrahepatic portosystemic shunt</keyword>
	<keyword>TIPS</keyword>
	<keyword>variceal bleeding</keyword>
	<keyword>liver cirrhosis</keyword>
	<keyword>hepatitis B</keyword>
</DOC>